Global Clinical Chemistry Analyzer Market Insights Forecasts to 2030
- The Clinical Chemistry Analyzer Market was valued at USD 15.01 Billion in 2021.
- The market is growing at a CAGR of 5.87% from 2022 to 2030
- The global Clinical Chemistry Analyzer Market is expected to reach USD 25.22 Billion by 2030
- Asia Pacific is expected to grow the fastest during the forecast period
Get more details on this report -
The Global Clinical Chemistry Analyzer Market is expected to reach USD 25.22 Billion by 2030, at a CAGR of 25.22% during the forecast period 2022 to 2030.
In the field of clinical pathology known as clinical chemistry, body fluids are analysed and evaluated with the goal of aiding in disease diagnosis and treatment. They are used to assess the metabolic processes and find disorders like diabetes and drug abuse. Clinical analyzers are automated equipment that analyse bodily fluids like blood serum, plasma, and urine using methods like ion-selective potentiometry, latex agglutination, photometric & colorimetric testing, and more. Benchtop analyzers, compact bedside variants with fewer test possibilities, and high-throughput floor-based machines are a few of the clinical analyzers on the market today.
Impact of COVID 19 On Global Clinical Chemistry Analyzer Market
COVID 19 pandemic has negatively affected the global clinical chemistry analyzer market owing to nationwide lockdowns across the world that has forced the people to live inside and this has resulted into the slow down of the pace of testing. Apart from this high cost associated with setup costs as well as shortage of laboratory professions provide huge assist cost within the equipment maintenance that has resulted into the prevention of the market development. Having said that increasing initiatives taken by the government withing diagnostics rane along with the innovative advancement provides market growth.
Global Clinical Chemistry Analyzer Market Report Coverage
|Market Size in 2021:
|USD 15.01 Bn
|Forecast Period 2021-2030 CAGR:
|2030 Value Projection:
|USD 25.22 Bn
|Historical Data for:
|No. of Pages:
|Tables, Charts & Figures:
|By Product, By Test, By End-Use, by Region.
|Abbott Diagnostics, Beckman Coulter, Elitech Group, Horiba Ltd., Johnson & Johnson, Mindray Medical International Ltd., Ortho-Clinical Diagnostics, Randox Laboratories Ltd., Roche Diagnostics, Siemens AG, Thermo Fisher Scientific.
|Pitfalls & Challenges:
|COVID-19 Empact, Challenge, Future, Growth, & Analysis
Get more details on this report -
Key Driving Factors
Automated clinical chemistry analyzers are gaining popularity owing to considerable technological breakthroughs as well as expansion the demand of healthcare industry, the adoption of clinical chemistry analyzers have increased on a fastest pace over the past few years. Clinical chemistry analysers provide accurate Diagnostic information and concentrate on the testing of internal bodily fluids. Modern clinical chemistry consists of a solid Foundation due to the presence of traditional manual laboratory techniques but as the technology started to develop the testing procedures started changing and many medical examinations need to carry out in an automated laboratories with the help of advantage equipment such as chemical analysers. Moreover, the market has witnessed severe advancement in the field of Technology due to the ongoing research and development initiative as well as the incorporation of innovative software technology in clinical laboratories. It is also possible that the market players may come up with new products in line which are mostly needed by the laboratories.
Key Market Challenges
The requirement of large capital investment keeps on growing but there is a shortage of laboratory technicians. Only hospitals and reference Laboratories have the budget to buy such high volume of clinical chemistry analyser which is affecting the market growth. In fact both develop and developing countries are facing the shortage of laboratory professionals due to the increasing patient population financially trapped institutions and retiring technicians which resulted into the shortage of the number of lab technicians and pathologists. All these factors are expected to hinder the market growth.
Reagents segment is dominating the market with the largest market share over the forecast period
On the basis of product, the global clinical chemistry analyzer market is segmented into analyzers, reagents, others. Among these, the reagents segment is dominating the market with the largest market share over the forecast period. The substantial market share is expected to be caused by the industry's abundant supply of reagents, which are offered to meet a variety of clinical demands. These reagents' key components include lipids, enzymes, certain proteins, substrates, electrolytes, and other things.
Basic Metabolic Panel segment is dominating the market with the largest market share over the forecast period
Based on test, the global clinical chemistry analyzer market is segmented into Basic Metabolic Panel, Electrolyte Panel, Liver Panel, Lipid Profile, Renal Profile, Thyroid Function Panel, Specialty Chemical Tests. Among these, the basic metabolic panel segment holds the largest market share and is dominating the market over the forecast period due to the increasing prevalence of lifestyle based health issues such as obesity and other metabolic abnormalities is rising. The increase the demand as well as the awareness of point of care testing plays a crucial role in the segmental growth.
End Use Insights
Hospitals segment holds the largest market share over the forecast period
On the basis of end use, the global clinical chemistry analyzer market is segmented into Hospitals, Academic Research Centers, Diagnostic Laboratories, Others. Among these, hospitals segment holds the largest market share over the forecast period due to the massive number of samples, increasing number of patients, and increasing readmission rates. The development of the hospital segment is also aided by supportive infrastructure that makes it possible for successful diagnostic operations. One of the key causes of the segment's sizable share is the rising number of government efforts intended to encourage effective diagnostic facilities to generate speedy findings and boost overall efficiency.
North America is dominating the market with the largest market share over the forecast period
Get more details on this report -
North America is dominating the Clinical Chemistry Analyzer market among all other regions due to the rising healthcare expenditure as well as the increasing popularity of point-of-care testing. Apart from this, increase in the product launches are anticipated to boost the regional market growth over the forecast period.
Asia Pacific, on the other hand, is witnessing the fastest market growth over the forecast period due to the strong of the key market players. Apart from this, the development of highly advanced healthcare infrastructure is anticipated to boost the regional market growth.
Recent Market Developments
- In May 2022, In the course of its extensive clinical study, AVEIR DR i2i, Abbott unveiled the first dual-chamber pacemaker implanted in a patient. The pivotal study's first worldwide implant of Abbott's innovative dual-chamber leadless pacemaker marks a significant advancement in leadless pacing technology.
List of Key Companies
- Abbott Diagnostics
- Beckman Coulter
- Elitech Group
- Horiba Ltd.
- Johnson & Johnson
- Mindray Medical International Ltd.
- Ortho-Clinical Diagnostics
- Randox Laboratories Ltd.
- Roche Diagnostics
- Siemens AG
- Thermo Fisher Scientific
This study forecasts revenue at global, regional, and country levels from 2019 to 2030. Spherical Insights has segmented the global Clinical Chemistry Analyzer Market based on the below-mentioned segments:
Clinical Chemistry Analyzer Market, Product Analysis
Clinical Chemistry Analyzer Market, Test Analysis
- Basic Metabolic Panel
- Electrolyte Panel
- Liver Panel
- Lipid Profile
- Renal Profile
- Thyroid Function Panel
- Specialty Chemical Tests
Clinical Chemistry Analyzer Marker, End Use Analysis
- Academic Research Centers
- Diagnostic Laboratories
Clinical Chemistry Analyzer Market, Regional Analysis
- North America
- Rest of Europe
- Asia Pacific
- South Korea
- Rest of Asia Pacific
- South America
- Rest of South America
- Middle East & Africa
- Saudi Arabia
- South Africa
- Rest of Middle East & Africa
Frequently Asked Questions (FAQ)
1. What is the market size of Clinical Chemistry Analyzer Market?The global Clinical Chemistry Analyzer Market is expected to grow from USD 15.01 Billion in 2021 to USD 25.22 Billion by 2030, at a CAGR of 5.87% during the forecast period 2022-2030.
2. Who are the key market players of Clinical Chemistry Analyzer Market?Some of the key market players of Clinical Chemistry Analyzer Market are Abbott Diagnostics, Beckman Coulter, Elitech Group, Horiba Ltd., Johnson & Johnson, Mindray Medical International Ltd., Ortho-Clinical Diagnostics, Randox Laboratories Ltd., Roche Diagnostics, Siemens AG, Thermo Fisher Scientific.
3. Which segment hold the largest market share?Alcohol detection hold the largest market share is going to continue its dominance.
4. Which region is dominating the Clinical Chemistry Analyzer Market?North America is dominating the Clinical Chemistry Analyzer Market with the highest market share.
Need help to buy this report?